Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05894265 · ClinicalTrials.gov registry record · NA
Prospective Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft Active Matrix (AM) vs. Standard of Care in Arthroscopic Rotator Cuff Repair
A NA study of Rotator Cuff Tears, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05894265: Recruiting NA study of Rotator Cuff Tears, sponsored by The University of Texas Health Science Center, Houston.
NCT05894265 is a NA study of Rotator Cuff Tears that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 60 participants, below the 1,278-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05894265, a NA study of Rotator Cuff Tears, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see how well the ActiveMatrix® graft works at improving healing and function of the shoulder following rotator cuff repair surgery
Primary Outcome
Sugaya classification is a classification system that is used to analyze postoperative rotator cuff tendon integrity
Conditions Studied
Interventions
- OTHER ActiveMatrix® Dosage A
- OTHER ActiveMatrix® Dosage B
- PROCEDURE Saline injection
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-06-14 |
| Est. Completion | 2026-08-01 |
| Phase | NA |
What NCT05894265 shows while recruiting
NCT05894265 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,278-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Rotator Cuff Tears appearing as the primary indexed condition, and to 3 interventions - of which ActiveMatrix® Dosage A is the first listed.
NCT05894265 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05894265 about?
NCT05894265 is a clinical study titled "Prospective Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft Active Matrix (AM) vs. Standard of Care in Arthroscopic Rotator Cuff Repair". The purpose of this study is to see how well the ActiveMatrix® graft works at improving healing and function of the shoulder following rotator cuff repair surgery
What is the current status of trial NCT05894265?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-06-14. Estimated completion is 2026-08-01.
What conditions does trial NCT05894265 study?
This clinical trial studies the following conditions: Rotator Cuff Tears.
What interventions are being tested in trial NCT05894265?
The interventions under investigation include: ActiveMatrix® Dosage A (OTHER), ActiveMatrix® Dosage B (OTHER), Saline injection (PROCEDURE).
Who is sponsoring clinical trial NCT05894265?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05894265 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rotator Cuff Tears
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05894265's enrollment target sits among peer trials
60 13th of 20 higher than 6 of 20 other Rotator Cuff Tears trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rotator Cuff Tears trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
FiberLocker® System Augmentation of Rotator Cuff Repairs
RECRUITING · NA
-
InSpace Accelerated Rehabilitation Study
RECRUITING · NA
-
Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue
RECRUITING · NA
-
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
RECRUITING · NA
-
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
RECRUITING · NA
-
RSA Vs RCR for Massive RCTs
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI